CONSUN PHARMAC.GR.HD -10 (C1P) — Cash Flow Reinvestment Rate
CONSUN PHARMAC.GR.HD -10 (C1P) has a Cash Flow Reinvestment Rate of 1.80x as of December 2025, reinvesting €2.18 Billion (capex €68.48 Million plus investments €-2.11 Billion) from operating cash flow of €1.21 Billion. See CONSUN PHARMAC.GR.HD -10 (C1P) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CONSUN PHARMAC.GR.HD -10 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for CONSUN PHARMAC.GR.HD -10 across 5 annual periods. For the full cash flow conversion analysis, see CONSUN PHARMAC.GR.HD -10 operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for CONSUN PHARMAC.GR.HD -10 (2021–2025)
Year-by-year capital reinvestment analysis for CONSUN PHARMAC.GR.HD -10. See CONSUN PHARMAC.GR.HD -10 free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.80x | €2.18 Billion | €1.21 Billion | €68.48 Million | ▲ +708.6% |
| 2024 | 0.22x | €242.06 Million | €1.09 Billion | €109.00 Million | ▼ -39.4% |
| 2023 | 0.37x | €300.83 Million | €818.97 Million | €52.56 Million | ▼ -16.6% |
| 2022 | 0.44x | €417.26 Million | €947.68 Million | €51.59 Million | ▼ -2.7% |
| 2021 | 0.45x | €328.25 Million | €725.54 Million | €98.25 Million | — |